Vitrolife AB (publ)

OM:VITR Stock Report

Market Cap: SEK 21.2b

Vitrolife Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bronwyn Brophy O´Connor

Chief executive officer

SEK 17.4m

Total compensation

CEO salary percentage55.1%
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Apr 25
Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Mar 13
Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Estimating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Feb 20
Estimating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 27
Is Vitrolife (STO:VITR) A Risky Investment?

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Aug 21
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Jul 20
Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next

Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth

Jul 18
Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

Apr 03
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Mar 07
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05
Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Jan 05
Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Dec 15
Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 06
Is Vitrolife (STO:VITR) A Risky Investment?

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Aug 25
An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Vitrolife (STO:VITR) Could Easily Take On More Debt

Aug 03
Vitrolife (STO:VITR) Could Easily Take On More Debt

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

May 26
Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

Is Vitrolife (STO:VITR) A Risky Investment?

Jan 23
Is Vitrolife (STO:VITR) A Risky Investment?

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Oct 18
Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Sep 09
Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Jul 07
Is Vitrolife (STO:VITR) A Risky Investment?

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

May 26
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

CEO Compensation Analysis

How has Bronwyn Brophy O´Connor's remuneration changed compared to Vitrolife's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

SEK 498m

Dec 31 2024SEK 17mSEK 10m

SEK 513m

Sep 30 2024n/an/a

-SEK 4b

Jun 30 2024n/an/a

-SEK 4b

Mar 31 2024n/an/a

-SEK 4b

Dec 31 2023SEK 7mSEK 6m

-SEK 4b

Compensation vs Market: Bronwyn's total compensation ($USD1.78M) is above average for companies of similar size in the Swedish market ($USD1.10M).

Compensation vs Earnings: Bronwyn's compensation has been consistent with company performance over the past year.

CEO

Bronwyn Brophy O´Connor (50 yo)

1.8yrs

Tenure

SEK 17,354,000

Compensation

Ms. Bronwyn Brophy O´Connor is President and Chief Executive Officer at Vitrolife AB (publ) since joining from August 01, 2023. She has an impressive track record as a leader of global Life science and Med...

Leadership Team

NamePositionTenureCompensationOwnership
Bronwyn Brophy O´Connor
CEO & President1.8yrsSEK 17.35mno data
Helena Wennerström
Acting Chief Financial Officerless than a yearno datano data
Ermanno Sironi
Chief Operating Officerless than a yearno datano data
Claus Bisgaard
Senior Vice President of Technologiesno datano data0%
SEK 0
Olivia Natens
Senior Vice President of Sales & Marketing1.3yrsno datano data
Marcos Fernandez
Vice President Strategyno datano datano data
Jessica Jonasson
Chief HR Officerno datano datano data
Meishan Jin
Senior VP & GM of Chinano datano datano data
Rickard Ericsson
Senior Vice President Innovation1.3yrsno data0%
SEK 0
Ricardo Capella
Senior Vice President Genetic Services3.3yrsno data0%
SEK 0
Erin Schardt
Senior VP & GM of North Americano datano datano data

1.3yrs

Average Tenure

53yo

Average Age

Experienced Management: VITR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Henrik Blomquist
Director6yrsSEK 517.00k0.0081%
SEK 1.7m
Jon Sigurdsson
Chairman of the Board10.3yrsSEK 1.25m0.022%
SEK 4.8m
Lars Holmqvist
Independent Director7.3yrsSEK 467.00kno data
Pia Marions
Independent Director12.1yrsSEK 533.00k0.0037%
SEK 781.0k
Karen Sorensen
Independent Director4.9yrsSEK 500.00kno data

7.3yrs

Average Tenure

62yo

Average Age

Experienced Board: VITR's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 02:36
End of Day Share Price 2025/05/08 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vitrolife AB (publ) is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kallum TitchmarshBofA Global Research